← Eichor
Study identifier: NCT05513833 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky

Condition: Hearing Loss  ·  Sponsor: University of Arkansas

PhaseNA
Planned participants18000
Who can joinAll sexes, 3 Years to 11 Years
Healthy volunteersYes

About this study

This trial will evaluate a multilevel intervention (STAR model) that combines mobile health (mHealth) hearing screening tools with telemedicine technology for specialty care access in rural Kentucky schools. An initial version of the model was used in rural Alaska where telemedicine-based specialty referral improved both proportion of children receiving follow-up and time to follow-up. The refined STAR model will utilize an enhanced mHealth screening protocol that includes tympanometry for the detection of middle ear disease. The STAR model will also include a specialty telemedicine referral process in schools for children who refer school screening.

This description comes directly from the study's public registry record.

Talk to the study team

Susan Emmett, MD, MPH  ·  501-603-1212  ·  sdemmett@uams.edu

Samantha Robler, AuD,PhD  ·  907-434-0433  ·  skrobler@uams.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of KentuckyLexington, Kentucky, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05513833